We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Technique Helps Surgeons Identify Bacteria

By LabMedica International staff writers
Posted on 09 Nov 2011
A faster, less expensive method has been developed for identifying bacterial infections and determining their antibiotic resistance.

The technology known as Raman spectroscopy looks at the bacteria's infrared wavelengths and pinpoint unique patterns of molecular vibration in blood samples.

Surgeons at the Detroit Medical Center at Wayne State University (Detroit, MI, USA) observed 120 spectral patterns from four strains of antibiotic resistant Staphylococcus aureus: two that were sensitive to the antibiotic methicillin, one that was resistant to methicillin and a more stubborn form of Staphylococcus infection that has a reduced susceptibility to a last-resort antibiotic called vancomycin (RVS-MRSA).

Raman spectroscopy enabled the scientists to distinguish the methicillin, sensitive S. More...
aureus (MSSA) from methicillin resistant S. aureus (MRSA) with 90.2% accuracy. They also could tell the difference between MRSA and its more stubborn form, RVS-MRSA, with 96.3% accuracy. The S. aureus profiles were then entered into a statistical program to create a preformed model of the Raman spectra. When the surgeons tested new spectra, the program was 98% accurate in classifying the bacteria as one of the four strains.

The S. aureus profiles generated by Raman spectroscopy are among dozens of pathogen profiles being added to a database of other bacteria, viruses, malignant tumors, and fungi. The team is simultaneously developing a technology to integrate the pathogen database and the Raman spectroscopy technique into a hand-held device that would cut turnaround times for diagnostic test results from several hours to about 10 minutes.

Amy Riley Spencer, MD, who led the study said, "Currently, emergency room patients may have to wait about six hours before diagnostic tests can identify a Staphylococcus infection and another 24 to 72 hours to determine which antibiotics could treat it. Our findings suggest that Raman spectroscopy can identify the infection earlier and save money by treating the infection quicker instead of hoping an antibiotic is working and then switching when it does not."

The findings were reported on October 26, 2011 at the 2011 Annual Clinical Congress of the American College of Surgeons, held in San Francisco (CA, USA).

Related Links:

Detroit Medical Center


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.